How-Wen Ko

1.1k total citations
7 papers, 572 citations indexed

About

How-Wen Ko is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, How-Wen Ko has authored 7 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in How-Wen Ko's work include FOXO transcription factor regulation (2 papers), Cancer Cells and Metastasis (2 papers) and Genetic Syndromes and Imprinting (1 paper). How-Wen Ko is often cited by papers focused on FOXO transcription factor regulation (2 papers), Cancer Cells and Metastasis (2 papers) and Genetic Syndromes and Imprinting (1 paper). How-Wen Ko collaborates with scholars based in Taiwan, United States and United Kingdom. How-Wen Ko's co-authors include Mien‐Chie Hung, Chih-Teng Yu, Chih-Liang Wang, Chien-Ying Liu, Shu‐Min Lin, Horng-Chyuan Lin, Chun‐Hua Wang, Han-Pin Kuo, Yen Chu and Yi‐Cheng Wu and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Clinical Cancer Research.

In The Last Decade

How-Wen Ko

7 papers receiving 565 citations

Peers

Countries citing papers authored by How-Wen Ko

Since Specialization

Citations

This map shows the geographic impact of How-Wen Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by How-Wen Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites How-Wen Ko more than expected).

Fields of papers citing papers by How-Wen Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by How-Wen Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by How-Wen Ko. The network helps show where How-Wen Ko may publish in the future.

Co-authorship network of co-authors of How-Wen Ko

This figure shows the co-authorship network connecting the top 25 collaborators of How-Wen Ko. A scholar is included among the top collaborators of How-Wen Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with How-Wen Ko. How-Wen Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer 2018 ·Frontiers in Immunology ·Chih-Hsi Kuo, Chien-Ying Liu, Stelios Pavlidis, Yu-Lun Lo, Yen‐Wen Wang, Chih‐Hung Chen, How-Wen Ko, Fu‐Tsai Chung, (unknown), Tsai-Yu Wang, (unknown), (unknown), (unknown), Cheng‐Ta Yang	10
2	CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia 2016 ·Genetic Testing and Molecular Biomarkers ·(unknown), How-Wen Ko, Ying‐Chin Lin	17
3	GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers 2016 ·Oncotarget ·How-Wen Ko, Heng‐Huan Lee, Longfei Huo, Weiya Xia, (unknown), Jennifer L. Hsu, Long‐Yuan Li, Chien‐Chen Lai, Li-Chuan Chan, (unknown), Adam M. LaBaff, Hsin-Wei Liao, Seung-Oe Lim, Chia‐Wei Li, Yongkun Wei, Lei Nie, Hirohito Yamaguchi, Mien‐Chie Hung	34
4	MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis 2014 ·Journal of Clinical Investigation ·Chi-Hong Chao, (unknown), Meng‐Ju Wu, How-Wen Ko, Da Wang, Mien‐Chie Hung, Jer-Yen Yang, Chun–Ju Chang	95
5	Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells 2013 ·Clinical Cancer Research ·Hirohito Yamaguchi, Jennifer L. Hsu, Chun‐Te Chen, Ying‐Nai Wang, Ming‐Chuan Hsu, Sam S. Chang, Yi Du, How-Wen Ko, Roy S. Herbst, Mien‐Chie Hung	110
6	FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization 2011 ·Cancer Research ·Jen-Liang Su, Xiaoyun Cheng, Hirohito Yamaguchi, Yi-Wen Chang, (unknown), Dung‐Fang Lee, How-Wen Ko, Kuo‐Tai Hua, Ying‐Nai Wang, Michael Hsiao, Poshen B. Chen, Jung-Mao Hsu, Robert C. Bast, Gabriel N. Hortobágyi, Mien‐Chie Hung	39
7	Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer 2009 ·Journal of Cancer Research and Clinical Oncology ·Chien-Ying Liu, Yumin Wang, Chih-Liang Wang, Po‐Hao Feng, How-Wen Ko, Yun-Hen Liu, Yi‐Cheng Wu, Yen Chu, Fu‐Tsai Chung, Chih-Hsi Kuo, Kang-Yun Lee, Shu‐Min Lin, Horng-Chyuan Lin, Chun‐Hua Wang, Chih-Teng Yu, Han-Pin Kuo	267

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact